Trial Profile
A phase II, open label study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2022
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 30 Oct 2006 Status change
- 25 Sep 2005 New trial record.